Minimize

Chemicals Under Consideration, Recently Listed or Modified Under Proposition 65

Chemicals Under Consideration

Chemical

CAS No

Referred By

Date

End Point

Deltamethrin

52918-63-5

DART Committee

7/13/2011

Developmental/ Reproductive toxicant

Status: Pending.  Data Call-In and  public comment period closed 3/20/2012. Public Comments Received.

Notes:  OEHHA initiating development of Hazard Identification Materials for DART Committee.

Xylene

1330-20-7

DART Committee

7/13/2011

Developmental/ Reproductive toxicant

Status: Pending.  Data Call-In and public comment period closed 3/20/2012. Public Comments Received.

Notes:  OEHHA initiating development of Hazard Identification Materials for DART Committee.

Beta-Myrcene

123-35-3

NTP

2/10/2012

Cancer

Status: Pending. Request for Information 2/10/2012. Public Comment period ended 4/10/2012.

Notes: Public comments received urging OEHHA to forward the proposed listing to the Carcinogen Identification Committee.

Pulegone

89-82-7

NTP

2/10/2012

Cancer

Status: Pending.  Notice of intent to List filed on May 25, 2012.

Notes: Public comments received urging OEHHA to forward the proposed listing to the Carcinogen Identification Committee.

Benzophene

119-61-9

IARC

1/20/2012

Cancer

Status: Pending.  Comment period extended through 4/6/2012.

Notes: Public comments received.

Cocamide Diethanolamine

68603-42-9

IARC

1/20/2012

Cancer

Pending.  Comment period extended through 4/6/2012.

Notes: Public comments received.

Diethanolamine

111-42-2

IARC

1/20/2012

Cancer

Status: Pending.  Comment period extended through 4/6/2012.

Notes: Public comments received.

2-Methylimidazole

693-98-1

IARC

1/20/2012

Cancer

Pending.  Comment period extended through 4/6/2012.

Notes: Public comments received.

C.I. Disperse Yellow 3

2832-40-8

CIC

11/10/2011

Cancer

Status: Pending. Request for Information. Public comment period ended 1/10/2012.

Notes:  OEHHA to develop Hazard Identification Materials.

Dibenzanthracenes and dibenz[a,c]anthracene

215-58-7

CIC

11/10/2011

Cancer

Status: Pending. Request for Information. Public comment period ended 1/10/2012.

OEHHA to develop Hazard Identification Materials.

Hydrogen Cyanide and Cyanide Salts

Various

U.S. EPA

6/24/2011

Male reproductive toxicity

Pending.  Comment period extended through 8/31/2011.

Notes:  Public comments received.

Proposed or Recently Modified Listings, NSRLs and MADLS

Chemical

CAS No

Date

Referred By

Previous Level

New Level

Benzyl Butyl Phthalate (BBP)

85-68-7

6/1/2012

NTP

None. MADL proposed.

1,200 ug/day oral

Tris(1,3-dichloro-2-propyl) phosphate (TDCPP)

13674-87-8

6/1/2012

CIC

None. NSRL proposed.

5.4 ug/day

Chloroform

67-66-3

5/18/2012

DART

None. MADL Proposed

600 ug/day

Imazalil

35554-44-0

4/25/2012

U.S. EPA

None.  NSRL adopted.

11 ug/day

Polychlorinated biphenyls (PCBs)

27323-18-8

4/13/2012

U.S. EPA

NSRL:  0.09 ug/day

NSRL proposed 0.35 ug/day;  MADL proposed for 2.3 ug/day – both levels limited to food chain exposures.

Methanol

67-56-1

3/16/2012

NTP

None. Proposed MADLs: 47,000 ug/day (Inhalation) and 23,000 ug/day (Oral)

Comment period was extended to June 25, 2012.  Public meeting held May 7.

Trichloroethylene

3/16/2012

U.S. EPA

1992 NSRLs: 50 ug/day (oral); 80 ug/day (Inhalation)

Proposed NSRLS: 14 ug/day (oral)

50 ug/day (Inhalation)

Glass wool fibers (inhalable and bio-persistent)

N/A

11/18/2011

IARC

N/A

Changed listing to include fiber along with particles

Avermectin B1

71751-41-2

10/26/2011

U.S. EPA

None.  MADL adopted.

4.4 ug/day

Hexavalent Chromium

18540-29-9)

9/16/2011

U.S. EPA

Section 25707(b)(4) reference  CR6 poses no significant risk when ingested. 

OEHHA proposed to remove reference  as posing no significant risk when ingested.  Public comment period extended 10/21/2012. Pending.

Hexavalent Chromium

18540-29-9)

7/29/2011

U.S. EPA

None. MADL adopted.

8.2 ug/day (oral)

Recently Listed Chemicals

Chemical

CAS No

Referred  By

Listing Date

Endpoint

Isopyrazam

881685-58-1

U.S. EPA

7/24/2012

Cancer

3,3',4,4'-Tetrachloroazobenzene

14047-09-7

NTP

7/24/2012

Cancer

Methanol

67-56-1

NTP

3/16/2012

Developmental

Methyl Isopropyl Ketone

563-80-4

ACGIH

2/17/2012

Developmental

Kresoxim-methyl

143390-89-0

U.S. EPA

2/3/2012

Cancer

Estrogen–progestogen (combined) used as menopausal therapy

N/A

IARC

11/4/2011

Cancer

Etopside

33419-42-0

IARC

11/4/2011

Cancer

Etoposide in combination with cisplatin and bleomycin

N/A

IARC

11/4/2011

Cancer

Methyl isobutyl ketone

108-10-1

IARC

11/4/2011

Cancer

MOPP (vincristine-prednisone-nitrogen mustard-procarbazine mixture)

113803-47-7

IARC

11/4/2011

Cancer

Tris(1,3-dichloro-2-propyl) phosphate (TDCPP)

13674-87-8

CIC

10/28/2011

Cancer

Titanium dioxide (airborne, unbound particles of respirable size)

N/A

CIC

9/2/2011

Cancer

Sulfur Dioxide

7446-09-5

DART

7/29/2011

Developmental

α-Methyl styrene

98-83-9

ACGIH

7/29/2011

Female Reproductive Toxicity

Imazalil

35554-44-0

U.S. EPA

5/20/2011

Cancer


Home   |   Job Board   |   About Us   |   Contact Us   |   Subscribe   |   ExpertSignup   |   Chemicals Under Consideration